AstraZeneca

AstraZeneca Faces "Tremendous Operational Challenges"

AstraZeneca Faces "Tremendous Operational Challenges"

Motley Fool

Moody's sees pick-up in pharmaceutical industry M&A in 2013

Moody's sees pick-up in pharmaceutical industry M&A in 2013

Reuters

AstraZeneca, Alchemia in multi-target drug discovery collaboration

AstraZeneca, Alchemia in multi-target drug discovery collaboration

Yahoo/Fly on the Wall

Top AstraZeneca investor backs Soriot and his 'golden hello'

Top AstraZeneca investor backs Soriot and his 'golden hello'

Fierce Pharma

AstraZeneca bets on nanotech with Bind Therapeutics deal

AstraZeneca bets on nanotech with Bind Therapeutics deal

Reuters

Top 10 pharma companies by employees

Top 10 pharma companies by employees

Fierce Pharma

Array's Up-Coming Value Enhancing Catalysts

Array's Up-Coming Value Enhancing Catalysts

Seeking Alpha

Pfizer's New Breast Cancer Drug Could Be A Game Changer

Pfizer's New Breast Cancer Drug Could Be A Game Changer

Seeking Alpha

Why GlaxoSmithKline Beats AstraZeneca and Shire

Why GlaxoSmithKline Beats AstraZeneca and Shire

Motley Fool

Firm ranks top 5 biotech deals in evolving pharma R&D landscape

Firm ranks top 5 biotech deals in evolving pharma R&D landscape

Fierce Biotech